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Abstract
 
Asthma is caused by memory Th2 cells that often arise early in life and persist after repeated
encounters with allergen. Although much is known regarding how Th2 cells develop, there is
little information about the molecules that regulate memory Th2 cells after they have formed.
Here we show that the costimulatory molecule OX40 is expressed on memory CD4 cells. In
already sensitized animals, blocking OX40–OX40L interactions at the time of inhalation of
aerosolized antigen suppressed memory effector accumulation in lung draining lymph nodes
and lung, and prevented eosinophilia, airway hyperreactivity, mucus secretion, and Th2 cyto-
kine production. Demonstrating that OX40 signals directly regulate memory T cells, antigen-
experienced OX40-deficient T cells were found to divide initially but could not survive and
accumulate in large numbers after antigen rechallenge. Thus, OX40–OX40L interactions are
pivotal to the efficiency of recall responses regulated by memory Th2 cells.
Key words: OX40 • asthma • memory T cells • Th2 • allergy
 
Introduction
 
Memory Th2 cells secreting the cytokines IL-4, IL-5, IL-9,
and IL-13 are the major driving force behind allergic
asthma and these CD4 cells are thought in many cases to
arise early in life during infancy (1, 2). Although the immu-
nological mechanisms that result in the development of
Th2 cells are fairly well characterized, there is a lack of
knowledge regarding how an already formed memory Th2
cell is regulated. Hence, it is not clear if there are certain
molecular interactions that could be targeted to either
suppress ongoing lung inflammation or to prevent the re-
occurrence of asthmatic symptoms when airborne allergens
are repeatedly encountered.
Apart from TCR signals that arise from peptide/MHC
recognition, the most likely sources of positive signals that
could affect longevity and/or reactivity of memory T cells
are membrane bound costimulatory molecules of the Ig and
TNFR superfamilies. Although there is abundant data on
the requirement of members of these families in controlling
priming of naive T cells and hence dictating the develop-
ment of memory Th2 cells, there is little data on whether
they can influence reactivity or persistence of a memory T
cell once it has been generated. In fact several groups postu-
lated that memory T cells are less dependent, or indepen-
dent, of costimulation, largely based on negative data ob-
tained from analyses of the Ig family member CD28 (3–8).
In contrast to CD28, it has become clear in the past few
years that a number of additional receptors exist that could
be crucial to a T cell response. Most significantly, recent
data on OX40 (CD134), a member of the TNFR family,
has shown that it is a major regulator of antiapoptotic pro-
teins such as Bcl-xL and Bcl-2 and strongly promotes the
survival of antigen-activated primary CD4 T cells (9–11).
OX40 is not constitutively expressed on naive T cells but is
induced in a primary immune response 24–48 h after rec-
ognition of antigen (9, 12–14). OX40L, a member of the
TNF family, is also inducible (9, 14, 15) being expressed on
activated B cells (15, 16), dendritic cells (17), and macro-
phage-like cells (18). The importance of OX40 costimula-
tion in priming naive T cells has been demonstrated in a
variety of basic and disease-related systems using OX40-
and OX40L-deficient animals, and in blocking studies (10,
11, 18–27). However, to date no studies have addressed
whether OX40–OX40L interactions contribute to the
maintenance and functionality of antigen-specific memory
T cells.
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OX40 is down-regulated to low levels after the effector
phase of primary T cell responses, and antigen-primed
CD4 T cells can rapidly up-regulate its expression upon re-
encounter with antigen (9). Similarly, an anergic T cell,
which also represents an antigen-experienced cell, albeit
functionally hyporesponsive, can also express OX40 at low
levels and be receptive to OX40 engagement resulting in
enhanced functionality (28). These observations suggest
that, similar to naive T cells, OX40 may play an important
role in a range of memory T cell activities, including sur-
vival and effector function. Hence, OX40 may be an at-
tractive target for suppressing already formed memory Th2
cells that mediate allergic asthma.
In the present study we demonstrate that some CD4 cells
in an already sensitized animal express OX40 and that co-
stimulation through this molecule is critical for all aspects
of lung inflammation driven by these memory Th2 cells.
These studies directly show that the recall response of
memory T cells is not costimulation independent, and can
be controlled by OX40 signals. They also suggest that tar-
geting OX40–OX40L interactions may be useful therapeu-
tically for the modulation of ongoing chronic inflammation
in allergic disorders.
 
Materials and Methods
 
Mice.
 
The studies reported here conform to the principles
outlined by the animal Welfare Act and the National Institutes of
Health guidelines for the care and use of animals in biomedical
research. 6–8-wk-old female C57BL/6 mice were purchased
from The Jackson Laboratory. OT-II TCR transgenic mice,
originally generated by Barnden et al. (29), were a gift from Dr.
W. Heath, and used as a source of V
 
 
 
5/V
 
 
 
2 CD4
 
 
 
 T cells re-
sponsive to peptide 323–339 of OVA. OX40-deficient OT-II
TCR transgenic mice were generated in house by crossing OT-II
mice with OX40
 
 
 
/
 
 
 
 mice.
 
Induction of Allergic Airway Inflammation.
 
The protocol for in-
duction of pulmonary inflammation via antigen sensitization and
aerosol challenge has been described previously (22). Briefly,
groups of 4 C57BL/6 mice were sensitized by i.p. injection of 20
 
 
 
g OVA protein (chicken egg albumin; Sigma-Aldrich), ad-
sorbed to 2 mg aluminum hydroxide (Alum; Pierce Chemical
Co.) in PBS on day 0. Unsensitized (naive) mice received 2 mg
Alum in PBS. On day 25 or later, mice were challenged via the
airways with OVA (5 mg/ml in 15 ml of PBS) for 30 min, once a
day for four consecutive days, by ultrasonic nebulization (22). To
block OX40–OX40L interaction, mice were injected i.p. with
200 
 
 
 
g of rat anti–mouse-OX40L blocking mAb (RM134L, rat
IgG2b
 
 
 
; reference 30) or isotype control antibody IgG2b; given
on the indicated days in PBS, 30 min before OVA challenge.
 
Analysis of the Asthma Phenotype.
 
Airway hyperreactivity
(AHR)
 
* 
 
was measured in vivo 1–3 h after the last aerosolized
OVA exposure by recording respiratory curves by whole-body
plethysmography (Buxco Technologies) in response to inhaled
methacholine (MCh; 1.25–10 mg/ml; Aldrich Chemical) as de-
scribed (22). Bronchoalveolar lavage (BAL) cytology, lung histo-
pathology, OVA-specific and total IgE and lung cytokine profiles
obtained by ELISA were determined as described (22). All data
unless otherwise stated were collected 24 h after the final antigen
challenge.
 
Stimulation of Lung, Peribronchial Lymph Node, and Spleen Cells
In Vitro.
 
Peribronchial lymph nodes (PBLNs) and spleens were
collected at the time of lung harvest. Lavaged lungs were digested
with HBSS (GIBCO BRL) supplemented with 3 mg/ml collage-
nase (Type V; Boehringer), 0.1 mg/ml Dnase (Sigma-Aldrich),
100 
 
 
 
g/ml streptomycin (Invitrogen), and 100 U/ml penicillin
(Invitrogen) for 60 min at 37
 
 
 
C. After lysing RBCs with ACK ly-
sis buffer, PBLN, spleen, and lung cells were resuspended in
RPMI-1640 medium (GIBCO BRL) supplemented with 10%
FCS (Omega Scientific), 1% 
 
l
 
-glutamine (Invitrogen), 100 
 
 
 
g/ml
streptomycin, 100 U/ml penicillin, and 50 
 
 
 
M 2-mercaptoetha-
nol (Sigma-Aldrich). Splenocytes (2 
 
 
 
 10
 
5
 
 cells/well), lung cells
(8 
 
 
 
 10
 
5
 
 cells/well), or PBLN cells (2 
 
 
 
 10
 
5
 
 cells/well) were
plated in round-bottomed 96-well microtiter plates in 200 
 
 
 
l
with increasing concentrations of OVA (10–100 
 
 
 
g/ml) for 72 h
at 37
 
 
 
C. After 56 h, 1 
 
 
 
Ci of 3
 
H
 
-thymidine (ICN Biomedicals)
was added to each well. The cells were harvested 16 h later, and
thymidine incorporation measured using a Betaplate scintillation
counter. Each in vitro stimulation was performed in quadrupli-
cates. Supernatants were harvested after 40 h for cytokine analysis.
 
Generation and Adoptive Transfer of OVA-specific Th2 Cells.
 
Lymph node and spleen cells from wild-type (OX40
 
 
 
/
 
 
 
) OT-II
mice or OT-II OX40-deficient (OX40
 
 
 
/
 
 
 
) mice were pooled
and CD4 cells isolated as described previously (9). The purity of
CD4
 
 
 
 T cells was confirmed to be 
 
 
 
98% by FACS
 
®
 
 analysis. To
generate memory Th2 cells, naive T cells (10
 
6
 
 cells/ml) were cul-
tured in two ways: with plate-bound 
 
 
 
CD3 (3 
 
 
 
g/ml) and solu-
ble 
 
 
 
CD28 (10 
 
 
 
g/ml), or with 2 
 
 
 
 10
 
6
 
/ml syngeneic splenic
APCs and 0.1 
 
 
 
M OVA peptide, plus IL-2 (5 ng/ml), IL-4 (20
ng/ml), 
 
 
 
IFN-
 
 
 
 (10 
 
 
 
g/ml), and 
 
 
 
IL-12 (10 
 
 
 
g/ml), for 3 d at
37
 
 
 
C. At the end of this culture, cells were removed, washed, and
then cultured for another 3–6 d without further stimulation.
In some cases, primed T cells were labeled with CFSE (5- and
6-carboxyfluorescein diacetate succinimidyl ester C-1157; Molec-
ular Probes) and 2 
 
 
 
 10
 
6
 
 were injected into the tail vain of naive
C57BL/6 mice in 200 
 
 
 
l. 1 d after transfer of cells, mice were
challenged with inhaled OVA (5 mg/ml in 15 ml PBS) for 30 min
daily for 2 consecutive days. Animals were killed for analyses 1 d
later. Control mice received inhaled PBS only. In vivo cell division
and T cell accumulation were assessed by tracking transferred T
cells by flow cytometry based on coexpression of CFSE and V
 
 
 
2.
At the end of the primary culture, an aliquot of primed T cells
were retained to determine proliferation, survival, and cytokine
production in recall responses in vitro. 5 
 
 
 
 10
 
5
 
 CD4 T cells/ml
were recultured with 2 
 
 
 
 10
 
6
 
/ml syngeneic splenic APCs and
OVA peptide. IL-4, IL-5, IL-13, and IFN-
 
 
 
 levels from cell su-
pernatants were determined by ELISA at 40 h. Proliferation was
measured in triplicate by the incorporation of 
 
3
 
H-thymidine (1
 
 
 
Ci/well; ICN Pharmaceuticals) during the last 12 h of culture.
T cell survival was determined by trypan blue exclusion.
 
Flow Cytometry Analysis.
 
Cells were stained with FITC-con-
jugated anti-CD4, PE-conjugated anti-OX40, Cychrome-conju-
gated anti-CD44, or PE-conjugated anti-V
 
 
 
2 at 4
 
 
 
C for 30 min.
Immunostained cells were analyzed on a FACScan™ flow cy-
tometer (Becton Dickinson) using the CELLQuest™ software.
 
Results
 
OX40 Is Expressed on Memory Th2 Cells.
 
Characteris-
tic features of allergic asthma are produced when mice are
 
*
 
Abbreviations used in this paper:
 
 AHR, airway hyperreactivity; BAL, bron-
choalveolar lavage; PBLN, peribronchial LN
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sensitized with OVA, and subsequently challenged several
weeks later by inhalation of OVA (1, 22). Using OX40-
deficient mice, we previously showed the importance of
OX40 in controlling initial development of asthma symp-
toms (22). However, as these mice are defective in generat-
ing a primary T cell response (10, 11), no conclusions
could be drawn regarding any requirement for OX40 in
the secondary response of the memory T cell that ulti-
mately induces lung inflammation.
We initially looked to see if memory CD4 cells express
OX40. By staining T cells from mice primed 4 wk prior
with OVA in alum, we visualized a significant number of
CD44
 
hi
 
 memory CD4 cells in lymph nodes that expressed
OX40 at low/moderate levels. In contrast, as shown previ-
ously (9), CD44
 
lo
 
 naive CD4 cells did not express OX40
without antigen exposure (Fig. 1 A). Unimmunized mice
also contained a proportion of CD44
 
hi
 
 CD4 cells that ex-
pressed OX40 at low levels (unpublished data), suggesting
that OX40 can be readily available to some memory T
cells. OX40 levels were up-regulated on responding
CD44hi memory T cells in lung draining lymph nodes af-
ter challenge with aerosolized antigen (Fig. 1 A), and the
absolute number of OX40 positive CD44
 
hi 
 
CD4 cells in-
creased markedly (Fig. 1 C, and see below). As this large
increase in the number of OX40-expressing CD44
 
hi
 
 cells
was not seen in unprimed mice challenged with aerosolized
antigen, the latter directly reflects the response of memory
T cells and accumulation of memory effector cells.
Few CD4 cells were present in the lungs of primed but
unchallenged mice, and OX40 was not detected on either
CD44
 
hi
 
 or CD44
 
lo
 
 cells (Fig. 1 B). However, after anti-
gen challenge, a large number of OX40-expressing CD4/
CD44
 
hi
 
 cells were seen in the lung (Fig. 1 B, and see below).
Analysis of lung sections revealed the presence of OX40
 
 
 
cells in peribronchial and perivascular areas, sites previously
shown to contain the majority of antigen-responding mem-
ory effector T cells (Fig. 1 D). These data show that OX40
is expressed on memory/memory effector T cells and sug-
Figure 1. OX40 is expressed on memory and memory effector T cells. Groups of four C57BL/6 mice were immunized i.p. with OVA adsorbed to
alum (primed). 25 d later mice were challenged by inhalation of nebulized OVA on 4 consecutive days (primed/challenged). (A) Peribronchial lymph
nodes or (B) lungs were examined for expression of OX40 on CD4/CD44lo or CD4/CD44hi T cells. (C) Total numbers of OX40 positive CD4/CD44hi
T cells (mean of 4 mice) were quantitated in lymph nodes from primed mice challenged with PBS (Alum-OVA/PBS), primed mice challenged with
OVA (Alum-OVA/OVA), or unprimed mice challenged with OVA (Alum/OVA). (D) Lung sections were prepared 24 h after the last aerosol challenge
and were stained with isotype matched control Ig (top) or anti-OX40 (bottom). A brown reaction product indicates OX40 staining. Similar results were
seen in three experiments.T
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gest that it is available to play a role during the secondary re-
sponse that occurs after reencounter with antigen.
 
Preventing OX40/OX40L Interaction Impairs Development
of Airway Hyperreactivity and Eosinophilia.
 
To examine the
contribution of OX40/OX40L interactions to lung inflam-
mation, we administered a blocking anti-OX40L mAb to
OVA-sensitized mice at the time of rechallenge with aero-
solized antigen (Fig. 2 A). OVA-immunized mice treated
with the isotype control developed increases in AHR
whereas administration of anti-OX40L dramatically reduced
the degree of AHR (Fig. 2 B). Sensitized mice treated with
control Ab during aerosol challenge (Alum-OVA/IgG-
OVA) responded with an increase in the total number of
cells in BAL (Fig. 2 C), which was evident as early as 48 h
and was mostly eosinophils (Fig. 2 D). In striking contrast,
administration of anti-OX40L during the challenge period
(Alum-OVA/RM134L-OVA) virtually eliminated the in-
crease in total leukocytes (Fig. 2 C) and eosinophils (Fig. 2
D). As no cell infiltration was seen in unprimed but chal-
lenged animals, this directly shows that OX40/OX40L in-
teractions were essential to the recall response.
 
Blocking OX40/OX40L Interactions Inhibits the Develop-
ment of Airway Tissue Eosinophilia, Goblet–Cell Hyperplasia,
and Mucus Production.
 
To support the findings from lung
lavages we conducted histological evaluations on lung sec-
tions. Mice receiving control Ab developed inflammatory
lesions, characterized by a predominance of eosinophils and
lymphocytes (Fig. 3, A and C), together with hyperplasia of
the mucus-secreting bronchial epithelial cells (Fig. 3 A). In
contrast, lungs from anti-OX40L treated animals had al-
most normal bronchial epithelium, and a minimum of infil-
trating cells around the bronchioles and blood vessels (Fig.
3, B and C). Many PAS
 
 
 
 (mucus-secreting) cells were de-
tected in the airway of mice that were sensitized and chal-
lenged and received the control Ab (Fig. 3, D and F),
whereas treatment with anti-OX40L markedly reduced the
number of PAS
 
 
 
 cells (Fig. 3, E and F).
 
Allergen-induced IgE and Th2 Cytokine Production Are Im-
paired in Anti-OX40L–treated Mice.
 
As an indirect test of
whether OX40 signals were controlling the memory Th2
response driving the asthmatic reaction, we measured cyto-
kine levels in the BAL and production of the Th2-associ-
ated antibody IgE in the serum. Treatment with anti-
OX40L prevented the increase in IgE that resulted from
the recall response (Fig. 3 G) and all Th2 cytokines (Fig. 3,
H–K) associated with the secondary response. IFN-
 
 
 
 was
either not present or at only low levels in all groups (un-
published data), suggesting that there was not a switch to a
Th1 response.
 
OX40 Signals Control Memory Effector T Cell Accumulation
in Secondary Lymphoid Organs.
 
To determine whether
functional antigen-reactive T cells were present in mice
where OX40 signals were blocked, OVA-specific prolifera-
tion and production of Th2 cytokines was measured in
vitro. Strong responses were seen in lung cell cultures from
OVA-primed and challenged mice but not in unprimed
challenged mice (Fig. 4, A and B, compare grp B and grp
A), again reflecting the memory effector response and that a
Figure 2. Anti-OX40L sup-
presses memory T cell induced
AHR and airway inflamma-
tion. (A) Experimental protocol
for anti-OX40L administration.
Unprimed control mice were in-
jected i.p. with alum alone
(Alum), while primed mice were
sensitized with OVA adsorbed to
alum (Alum-OVA). 25 d later,
all mice were challenged with
aerosolized OVA on 4 consecu-
tive days (days 25–28; indicated
by arrows). Either PBS (Group
A: Alum/OVA), or control IgG
(Group B: Alum-OVA/IgG-
OVA) or anti-OX40L (Group
C: Alum-OVA/RM134L-OVA)
were administered i.p. on each
challenge day. (B) 1–3 h after the
last aerosol challenge, individual
mice were assessed for AHR.
Results are the mean percent
change in Penh levels above
baseline (saline-induced AHR),
after exposure to increasing con-
centrations of inhaled methacho-
line. Values are calculated from
four mice in each group per ex-
periment. Similar results were seen in three experiments. (C) Total leukocyte numbers were enumerated in BAL at different times (0, 1, 2, 3, and 4 d) af-
ter exposure to aerosolized OVA (indicated by arrows). (D) Total numbers of eosinophils were calculated from differential stained BAL cytospins. Results
are the mean number of cells   SEM from two separate experiments with four mice per group in each experiment.T
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functional primary response did not result from exposure to
airborne antigen alone. Those animals treated with anti-
OX40L during the recall response showed little or no
OVA-specific T cell reactivity in the lungs (Fig. 4, A and B,
grp C). To test whether recall responses were absent at other
sites, spleen and lung draining lymph nodes were examined.
Greatly reduced OVA-reactivity was found in secondary
lymphoid organs after anti-OX40L treatment (Fig. 4, C and
D). These results suggest that the effect of OX40/OX40L
blockade is not tissue specific, but, rather, that OX40 signal-
ing is critical for the development of functional memory ef-
fector cells after memory T cells reencounter antigen.
As OX40 is only present on antigen-responding or anti-
gen-experienced T cells, we tracked the accumulation of
OX40-expressing CD4 cells over time. As shown in Fig. 4
(and Fig. 1), before antigen challenge, only a low number of
T cells expressed OX40. After OVA challenge, an large in-
crease was observed in the number of CD4
 
 
 
OX40
 
 
 
 cells in
the bronchial LN (Fig. 4 E), lung (Fig. 4 F), and BAL (Fig.
4 G) in primed and challenged mice, far greater than in
unprimed challenged mice, reflecting the population of re-
sponding memory effector T cells. The number of OX40
 
 
 
cells in the LN peaked at day 1, whereas the number in the
BAL rose progressively from day 2 over the 4-d aerosol ex-
posure. This suggests that the initial memory T cell response
developed in the secondary lymphoid organs, and within
24 h the T cells started to migrate to the lung. This cor-
relates with other published data (31). Significantly, treat-
Figure 3. Anti-OX40L inhibits lung infiltration, goblet cell hyperplasia, mucus, serum IgE, and BAL Th2 cytokine production. Groups of mice were
immunized and challenged as described in Fig. 2. 24 h after the final OVA aerosol challenge, lung tissue was stained with H&E ( 100) for quantitation
of inflammatory infiltrates (A and B) and periodic acid-Schiff (PAS,  200; purple-red staining) to highlight the mucus-secreting cells (D and E), in sen-
sitized and challenged animals receiving control Ig (A and D) or anti-OX40L (B and E). Sections were graded for inflammation severity (C) and mucus
production (F) with groups A (white bars), B (black bars), and C (gray bars) corresponding to those described in Fig. 2. Results are the mean score  
SEM from four separate experiments with four mice per group in each experiment. 24 h after the final OVA aerosol challenge, sera were analyzed for
OVA-specific IgE (G), and BAL were assessed for IL-4 (H), IL-5 (I), IL-9 (J), and IL-13 (K). Results are the mean values   SEM from two separate ex-
periments with four mice per group in each experiment.T
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ment of mice with anti-OX40L reduced the number of
CD4
 
 
 
OX40
 
 
 
 cells visualized in the LN at the peak of re-
sponse at day 1, and subsequently. Consequently, few acti-
vated OX40
 
 
 
 T cells were then observed in the lung and
BAL. These results suggest that OX40/OX40L interactions
are required early in the response of a memory T cell and
control the ability to expand in numbers and survive in or-
der to form a large population of memory effector T cells.
As further evidence for this, we performed kinetic
blocking experiments where mice received anti-OX40L 1,
2, or 3 d after the initial aerosol (Fig. 4, H and I). Although
delaying anti-OX40L treatment by 1 or 2 d reduced the re-
sponse by 50% and 30%, the most dramatic effect was seen
when OX40/OX40L interactions were inhibited at the
time of initial encounter with recall antigen.
 
Primed OX40-deficient OVA-specific Th2 Cells Do Not Sur-
vive Efficiently in Recall Responses.
 
To further investigate
the requirement for OX40 in recall responses of antigen-
primed Th2 cells, OVA-specific OX40-deficient CD4 cells
were produced by crossing OX40-knockout mice to OT-
II TCR transgenic mice. Naive CD4 cells from wild-type
(OX40
 
 
 
/
 
 
 
) or OX40-deficient (OX40
 
 
 
/ ) OT-II mice
were cultured in vitro with peptide and APCs under Th2
(IL-4, anti-IL-12, and anti-IFN- ) polarizing conditions
for a time period that allows primary T cell expansion and
contraction to proceed normally. Previous data have shown
that such in vitro–stimulated cells mimic in vivo generated
memory cells (32, 33) and can also be used in adoptive
transfer experiments to directly induce lung inflammation
(34, 35).
Restimulation of primed OX40 /  Th2 cells in vitro
with OX40L-sufficient APCs resulted in proliferation, ex-
pansion, survival, and production of Th2 cytokines (Fig. 5).
Primed OX40 /  T cells secreted Th2 cytokines normally,
suggesting that there is not a role for OX40 in this T cell
activity, and OX40 /  T cells also initially proliferated
comparably with wt T cells. However, far fewer T cells
survived in the secondary response in the absence of OX40
signals, which was also reflected in weak proliferation late
in culture (Fig. 5, A and B).
To determine if a similar requirement for OX40 was ap-
parent in vivo during a recall response to aerosolized anti-
gen, in vitro–primed T cells were labeled with CFSE,
adoptively transferred into naive recipients, and then these
mice were challenged intranasally with OVA (Fig. 6).
Challenge with PBS did not result in division (Fig. 6, A
and C) or expansion (Fig. 6, B and D) of either OX40 / 
or OX40 /  T cells in draining lymph nodes or lung.
Challenge with OVA resulted in pronounced division of all
OX40 /  T cells and accumulation in numbers was ob-
served in lymph nodes and particularly evident in the lung.
Correlating with the in vitro data, recovered OX40 /  T
cells displayed the same division profile as their wt counter-
parts (Fig. 6, A and C), but in total approximately fourfold
fewer accumulated at the end of the antigen challenge pe-
riod (Fig. 6, B and D). This directly mimicked the data ob-
tained by tracking OX40-expressing T cells after OX40L
blockade (Fig. 4, E–G). This shows that OX40 signals reg-
ulate the number of memory effector T cells that are gen-
erated after memory T cells reencounter antigen.
Primed OX40-deficient OVA-specific Th2 Cells Do Not Ef-
ficiently Promote Lung Inflammation. To correlate a lack of
expansion/survival of memory effector cells with reduced
lung inflammation, eosinophilia, lung histology, and Th2
cytokines were analyzed after adoptive transfer of primed
OX40 /  OT-II Th2 cells (Fig. 7). Transfer of wild-type
Figure 4. OX40 signals control memory T cell responses in secondary
lymphoid organs. Mice were immunized and challenged as in Fig. 2.
(A–D) 1 d after the last OVA challenge, lung (A and B), and lymph node
cells (C and D) were cultured in medium alone or in the presence of in-
creasing doses of OVA (10, 50, 100  g/ml). (A and C) Proliferation at 72 h
with 10  g/ml OVA. (B and D) IL-5 production (Group A: Alum/
OVA; Group B: Alum-OVA/IgG-OVA; Group C: Alum-OVA/
RM134L-OVA). Results are the mean   SEM from quadruplicate cul-
tures and are representative of three experiments. Similar results were ob-
tained for IL-13. (E–G) Peribronchial lymph node (E), lung (F), and BAL
(G) cells from unimmunized and challenged mice ( ), or OVA-immu-
nized and challenged mice treated with control Ab ( ) vs. anti-OX40L
Ab (O), were harvested before (day 0) or on the indicated days after the
first OVA challenge. T cells were stained for CD4 and OX40. The total
numbers of OX40  CD4 T cells were calculated from four mice in each
group after gating on viable CD4  T cells. Similar results were seen in
three experiments. (H and I) Total leukocyte (H) and eosinophil (I) num-
bers in BAL recovered from mice given anti-OX40L throughout the
aerosol challenge (day 0), or 1, 2, or 3 d after the initial aerosol. Results
are the mean   SEM from one experiment with four mice per group.T
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cells followed by repeated intranasal OVA challenge in-
duced profound inflammation accompanied by production
of Th2 cytokines in BAL (Fig. 7, A, C, and F). In contrast,
mice receiving OX40-deficient cells showed only a small
increase in the total numbers of eosinophils recovered from
the BAL (Fig. 7 A), relatively normal lung histology (com-
pare Fig. 7 E to 7 C), and reduced Th2 cytokines (Fig. 7
F). These results clearly show that OX40 expressed on a
memory Th2 cell is required for lung inflammation.
OX40/OX40L Interactions Control both Late Secondary and
Tertiary Recall Responses to Inhaled Antigen. As our initial
studies addressed the role of OX40 signals in the recall re-
sponse of what can been termed early memory T cells,
persisting 4 wk after primary immunization, we deter-
mined whether OX40/OX40L interactions were also crit-
ical to the response of memory T cells that persist for
longer periods of time and survive following a secondary
response. In one set of experiments, mice were primed for
8 wk and anti-OX40L administered during the secondary
response to aerosolized antigen (Fig. 8 A). Again, blocking
OX40 signals strongly inhibited all aspects of lung inflam-
mation, including total leukocyte (Fig. 8 B) and eosinophil
(Fig. 8 C) infiltration, and production of Th2 cytokines
(unpublished data). In further experiments, mice were
primed for 4 wk, challenged with aerosolized antigen in a
secondary response without blocking OX40L, rested for
13 wk, and then challenged again but with anti-OX40L
blockade (Fig. 8 D). Inhibiting OX40 signals during this
tertiary response again strongly inhibited lung inflamma-
tion (Fig. 8, E and F), with a greater than 50% reduction
in cellular infiltration. As no lung inflammation was ob-
served in unsensitized control mice that were repeatedly
exposed to aerosolized antigen, ruling out any primary re-
sponse (Fig. 8, E and F, grp A), these data demonstrate that
blocking OX40/OX40L interactions severely limits the
recall response of memory Th2 populations that can persist
for extended periods of time.
Discussion
Previous work has demonstrated that OX40 and OX40L
control the development of a number of primary T cell re-
sponses (9–11, 18–27) but no data has been presented re-
garding a role for these interactions in the recall response of
memory T cells. We now show the absolute importance of
OX40–OX40L interactions in antigen-specific memory
that mediates allergic lung inflammation. We demonstrate
that exposure of sensitized animals to antigen via the air-
ways is accompanied by large increases in the number of
OX40-expressing memory/memory effector Th2 cells,
both in the lungs and in secondary lymphoid organs, which
was closely associated with eosinophilia and the develop-
ment of airway hyperresponsiveness. Strikingly, preventing
OX40–OX40L interactions during the recall response in-
hibited the ensuing Th2 response and the associated asth-
matic symptoms. These results provide the first in vivo evi-
dence that memory T cells, like naive T cells, can require
Figure 5. Primed OX40 /  T
cells do not survive efficiently in
recall responses in vitro. OVA-
specific Th2 memory cells were
generated in vitro from wild-
type (OX40 / , closed symbols)
or OX40-deficient (OX40 / ,
open symbols) OT-II TCR
transgenic mice as described in
Materials and Methods. Primed
T cells were restimulated with
OVA peptide and APCs and
proliferation (A) and survival (B)
measured over 6 d. Cytokine
production (C) was measured at 40 h. Data are means   SEM from triplicate cultures, and representative of two separate experiments. Similar results
were obtained if naive T cells were stimulated with antigen or anti-CD3 in primary cultures.
Figure 6. Primed OX40 /  T cells do not accumulate efficiently in
recall responses in vivo. OVA-specific Th2 memory cells were generated
in vitro as in Fig. 5, from wild-type (OX40 / ) or OX40-deficient
(OX40 / ) OT-II TCR transgenic mice. Primed T cells were labeled
with CFSE and injected i.v. into naive C57BL/6 mice. Recipient mice
were subsequently exposed to inhaled OVA or PBS on two consecutive
days. 1 d after the last OVA challenge, peribronchial lymph node (A and
B) and lung (C and D) were analyzed by flow cytometry for division (A
and C) and accumulation (B and D) of transferred CFSE/V 2 positive
CD4 T cells. Data are representative of two separate experiments.T
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costimulation through OX40, and indicate that OX40–
OX40L interactions are potential targets for modulating
peripheral acute phase inflammatory responses.
Our recent data show that OX40 principally functions by
suppressing T cell death and does so by maintaining high
levels of antiapoptotic proteins such as Bcl-xL and Bcl-2
(11) and inhibiting expression or activity of proapoptotic
proteins such as Bad and Bim (unpublished data). This con-
clusion has been reinforced by in vivo studies where agonist
antibodies directed to OX40 on a responding naive CD4
cell enhanced primary T cell expansion and survival, and in
so doing promoted the development of greater numbers of
memory T cells (10, 36). The data here now complement
these studies and show that OX40 can act in the response of
a memory Th2 cell in an analogous manner and dictate the
expansion and persistence of antigen-specific memory ef-
fector T cells during recall lung inflammation.
Analysis of BAL and dispersed lung showed that anti-
OX40L reduced the absolute numbers of activated (OX40 )
memory effector T cells, potentially consistent with the idea
Figure 7. Primed OX40-deficient T cells cannot induce pronounced airway inflammation. OVA-specific Th2 memory cells were generated in vitro as
in Fig. 5, from wild-type (OX40 / ) or OX40-deficient (OX40 / ) OT-II TCR transgenic mice. Primed T cells were injected i.v. into naive C57BL/6
mice. Recipient mice were subsequently exposed to aerosolized OVA or PBS on two consecutive days. (A) Eosinophil numbers in BAL 24 h after the
last OVA challenge. Results are mean   SEM from four mice per group. (B–E) H&E stained lungs from mice receiving wild-type (B and C) or OX40-
deficient T cells (D and E) after challenge with PBS (B and D) or OVA (C and E). (F) IL-4, IL-5, and IL-13 levels in BAL from mice with wt T cells
challenged with PBS (Grp A), wt T cells challenged with OVA (Grp B), OX40 /  T cells challenged with OVA (Grp C). Similar results were seen in
three separate experiments.
Figure 8. OX40/OX40L in-
teractions control both late sec-
ondary and tertiary recall re-
sponses to inhaled antigen. (A)
Immunization protocol for sec-
ondary response of late memory
T cells. Unprimed control mice
were injected i.p. with alum
alone (Alum), while primed
mice were sensitized with OVA
adsorbed to alum (Alum-OVA).
60 d later, all mice were chal-
lenged with aerosolized OVA on
4 consecutive days (days 60–64;
indicated by arrows). Either PBS
(Group A: Alum/OVA), or con-
trol IgG (Group B: Alum-OVA/
IgG-OVA) or anti-OX40L
(Group C: Alum-OVA/
RM134L-OVA) were adminis-
tered i.p. on each challenge day
(indicated by filled symbols). (D)
Immunization protocol for ter-
tiary response of late memory T
cells. Unprimed control mice were injected i.p. with alum alone (Alum), while primed mice were sensitized with OVA adsorbed to alum (Alum-OVA).
On days 25–29 all mice were challenged in a secondary response with aerosolized OVA. 91 d later (day 120), all mice were challenged in a tertiary re-
sponse with aerosolized OVA on 4 consecutive days (days 120–124; indicated by arrows). Either PBS (Group A: Alum/OVA), or control IgG (Group B:
Alum-OVA/IgG-OVA) or anti-OX40L (Group C: Alum-OVA/RM134L-OVA) were administered i.p. on each challenge day (indicated by filled sym-
bols). 1 d after the last challenge mice were killed and airway eosinophilia and Th2 cytokine production determined. Total leukocyte (B and E) and eo-
sinophil (C and F) numbers were enumerated in BAL from mice in protocol A (B and C) and protocol D (E and F) respectively. Analysis of Th2 cyto-
kines showed the same profile as cell infiltration (unpublished data). Individual responses of four mice in each group are shown.T
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that OX40 could be involved in memory T cell recruit-
ment. However, low numbers of activated OX40  T cells
were also observed in secondary lymphoid organs, along
with reduced antigen-specific activity, supporting the notion
that preventing OX40/OX40L interactions did not simply
block T cells from entering the lung. Other studies of lung
inflammation have suggested that memory T cells do not
proliferate in the lung in response to intranasal antigen chal-
lenge, but proliferate in the lymph nodes (37). Moreover,
prior reports show that T cell emergence in the lung is only
appreciable 24–48 h after antigen reexposure (31), consistent
with the idea that expansion and survival signals are required
to generate a large pathogenic population. Our kinetic
blocking data showing maximal inhibition only when
OX40/OX40L interactions are absent at the time of initial
antigen challenge support this, along with the idea that
OX40 signals are required early (0–48 h) and most likely
provided in the secondary lymphoid organs. Further in line
with the idea that OX40 signals dictate the subsequent gen-
eration or survival of memory effector T cells after antigen
reactivation, primed OX40-deficient Th2 cells were found
capable of proliferating initially in the recall response, but
did not subsequently accumulate in high numbers.
Previous studies of memory T cells have largely con-
cluded that they had a reduced requirement for costimula-
tory signals and hence may not be susceptible to interven-
tions that target such membrane bound molecules (38). For
example, blocking B7–CD28 interactions during secondary
responses to the nematode parasites Heligmosomoides polygyrus
(7) and Nippostrongylus brasiliensis (8), or immunogenic anti-
mouse IgD antibody treatment (6), failed to inhibit memory
Th2 responses, whereas blocking CD28 at the time of prim-
ing was suppressive (6–8). These and other observations
therefore implied that activation of memory Th2 cells may
be costimulation, or at least B7/CD28, independent. How-
ever, in light of our data on OX40, rather than becoming
costimulation independent, T cells may shift after antigen
exposure to being more reliant on other molecules. Recent
studies from Gonzalo et al. (39) on an inducible Ig family
member, ICOS, also support this idea. These latter data in
another variant of the asthma model showed that blocking
B7RP-1–ICOS interactions effectively inhibited most asth-
matic symptoms at the time of allergen exposure, producing
an overall result similar to our data with OX40. Further-
more, this report showed that ICOS was active at a time
when CD28 was not a major factor. Unlike OX40, it has
been proposed that ICOS may primarily regulate cytokine
production (40) rather than T cell survival, and therefore it is
an intriguing idea that both of these molecules act in concert
but dictate distinct phases during the Th2 recall response.
In summary, our experiments show a critical role for
OX40/OX40L interactions in the recall response to in-
haled antigen, for the subsequent activation and recruit-
ment of memory effector CD4 T cells into the airway, and
for the induction of morphological changes to the airways
that are reminiscent of human asthma. As CD4  T cells
have been shown to play a critical role in both initiation
and maintenance of allergic pulmonary responses, our re-
sults have important ramifications for the development of
therapeutic strategies in which anti-OX40L antibodies,
alone or in combination with other therapies, can be used
in clinical situations where memory Th2 cells have been
implicated. Importantly, this approach has a distinct advan-
tage of blocking the production of several Th2 cytokines
simultaneously rather than suppressing the activity of a sin-
gle cytokine, and may profoundly affect the ability to con-
tinue to mount a Th2 response.
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